Pamt Corp (PAMT) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
27 Mar, 2026Executive summary
Annual meeting scheduled for April 30, 2026, to elect nine directors, approve executive compensation, and ratify the appointment of Grant Thornton LLP as independent auditor.
Shareholders of record as of March 11, 2026, are entitled to vote; each share of common stock has one vote.
Board recommends voting FOR all proposals, including director nominees, executive compensation, and auditor ratification.
Voting matters and shareholder proposals
Proposals include election of nine directors, advisory vote on executive compensation, and ratification of Grant Thornton LLP as auditor.
Board recommends FOR all proposals; plurality required for director election, majority for other proposals.
Shareholder proposals for the 2027 meeting must be received by November 27, 2026, for inclusion in proxy materials.
Board of directors and corporate governance
Board consists of nine directors, with four meeting NASDAQ independence standards.
Board structure separates Chairman and CEO roles; active risk oversight through Audit Committee and full Board.
Three standing committees: Audit, Compensation, and Executive; no separate nominating committee.
Controlled company status exempts from certain NASDAQ independence requirements.
Board diversity considered holistically; all directors attended at least 75% of meetings in 2025.
Latest events from Pamt Corp
- 2025 net loss deepened on lower revenues and a major auto-liability settlement; liquidity remains sufficient.PAMT
Q4 202512 Mar 2026 - Proxy seeks approval for director elections, equity plan, redomestication, share increase, and auditor.PAMT
Proxy Filing2 Dec 2025 - Annual meeting to vote on directors, equity plan, redomestication, and auditor ratification.PAMT
Proxy Filing2 Dec 2025 - Key votes include director elections, equity plan, Nevada move, share increase, and auditor ratification.PAMT
Proxy Filing2 Dec 2025 - Board seeks approval for director slate, auditor ratification, and highlights new equity plan.PAMT
Proxy Filing2 Dec 2025 - Net loss of $5.6M in Q3 and 17.7% revenue drop as operating ratios worsened.PAMT
Q3 20255 Nov 2025 - Revenue and profitability declined sharply in Q2 2025 amid persistent industry headwinds.PAMT
Q2 20258 Aug 2025 - Q3 2024 revenue and net income declined, but management expects market recovery.PAMT
Q3 202413 Jun 2025 - Net loss of $2.9M and 11.8% revenue drop as cost pressures and market headwinds persisted.PAMT
Q2 202413 Jun 2025